Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
28°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
3.910
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.910
Bid (Size)
3.850 (2)
Ask (Size)
4.100 (100)
Prev. Close
3.910
Today's Range
3.910 - 3.910
52wk Range
3.840 - 8.050
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
April 08, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Performance
YTD
-31.76%
-31.76%
1 Month
-15.00%
-15.00%
3 Month
-24.66%
-24.66%
6 Month
-8.86%
-8.86%
1 Year
-45.77%
-45.77%
More News
Read More
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
April 03, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Recap: AbCellera Biologics Q4 Earnings
February 20, 2024
Via
Benzinga
The 7 Best Penny Stocks to Buy in Q2 2024
March 27, 2024
Via
InvestorPlace
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
March 19, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
March 11, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Recap: These 7 Artificial Intelligence (AI) Stock Categories Had Returns From +2 To +15% In February
March 06, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
March 05, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Via
Talk Markets
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
Via
InvestorPlace
AbCellera Announces Resignation of Board Member
February 23, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at Upcoming Investor Conferences in March
February 22, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript
February 20, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AbCellera Reports Full Year 2023 Business Results
February 20, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Earnings Scheduled For February 20, 2024
February 20, 2024
Via
Benzinga
These 9 AI Stock Categories Performed From +18% To -4% Last Week
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
January 23, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond
January 16, 2024
Via
The Motley Fool
3 Growth Stocks That Could Go Parabolic in 2024
January 15, 2024
Via
The Motley Fool
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
Via
Talk Markets
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
December 20, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.